Testing effectiveness (Phase 2)Study completedNCT02103062What this trial is testingPhase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Celgene 41
Large-scale testing (Phase 3)Study completedNCT02053610What this trial is testingCLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)Who this might be right forLymphocytic Leukemia, Chronic Hoffmann-La Roche 787
Testing effectiveness (Phase 2)Study completedNCT04815720What this trial is testingPepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckWho this might be right forRecurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) Vaccinex Inc. 49
Not applicableUnknownNCT05310305What this trial is testingPD-1 Antibody and Radiotherapy for Recurrent Cervical CancerWho this might be right forImmune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more Lei Li 20
Testing effectiveness (Phase 2)UnknownNCT03799094What this trial is testingVitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor MutationsWho this might be right forCarcinoma, Non-Small-Cell Lung Clifford Hospital, Guangzhou, China 150
Not applicableUnknownNCT02851329What this trial is testingTherapeutic Resistance Prediction of Tyrosine Kinase InhibitorsWho this might be right forNon-small Cell Lung Cancer Chinese Academy of Sciences 500
Not applicableUnknownNCT05807165What this trial is testingHF-SRT vs. HS-WBRT in Treating Patients With Brain OligometastasesWho this might be right forBrain Oligometastases Chang Gung Memorial Hospital 115
Testing effectiveness (Phase 2)Looking for participantsNCT05257018What this trial is testingR-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS RelapseWho this might be right forDiffuse Large B-cell Lymphoma Fudan University 83
Not applicableEnded earlyNCT01277120What this trial is testingAn Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Colorectal Cancer (CRONOS 1)Who this might be right forColorectal Cancer Hoffmann-La Roche 174
Not applicableStudy completedNCT02751138What this trial is testingDetermination of Immune Phenotype in Glioblastoma PatientsWho this might be right forGlioblastoma Multiforme University of Ulm 100
Not applicableStudy completedNCT02392078What this trial is testingLaser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate SystemWho this might be right forMetastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more Monteris Medical 1,153
Large-scale testing (Phase 3)Study completedNCT00022672What this trial is testingEvaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 208
Large-scale testing (Phase 3)Study completedNCT00944918What this trial is testingStudy of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)Who this might be right forProgression-free Survival AstraZeneca 25
Testing effectiveness (Phase 2)Study completedNCT01328574What this trial is testingTRC105 in Adults With Advanced/Metastatic Urothelial CarcinomaWho this might be right forUrothelial CarcinomaUreteral NeoplasmsUreter Cancer+2 more National Cancer Institute (NCI) 13
Not applicableLooking for participantsNCT06273176What this trial is testingThe RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent GlioblastomaWho this might be right forGlioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more Erasmus Medical Center 225
Testing effectiveness (Phase 2)Study completedNCT03359018What this trial is testingApatinib Plus Anti-PD1 Therapy for Advanced OsteosarcomaWho this might be right forProgression-free SurvivalOverall SurvivalClinical Benefit Rate+1 more Peking University People's Hospital 43
Not applicableUnknownNCT00900289What this trial is testingStudying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial CancerWho this might be right forOvarian Cancer Liz-Anne Lewsley 1,000
Testing effectiveness (Phase 2)Study completedNCT00520403What this trial is testingAvastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.Who this might be right forRenal Cell Cancer Hoffmann-La Roche 25
Testing effectiveness (Phase 2)Study completedNCT00800202What this trial is testingAvastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain MetastasisWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 91
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07405736What this trial is testingLubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal CancerWho this might be right forColorectal Cancer MetastaticPeritoneal (Metastatic) CancerPeritoneal Metastasis+2 more Sun Yat-sen University 124